Form 4: Director E. Kevin Hrusovsky Equity Transactions

Director E. Kevin Hrusovsky reported the vesting of restricted stock units and the acquisition of new equity awards in 908 Devices Inc.

Summary

• Director E. Kevin Hrusovsky acquired 14,083 shares of common stock through the vesting of restricted stock units (RSUs) on June 10, 2026.
• The director was granted 13,656 new RSUs on June 11, 2026, which are scheduled to vest on June 11, 2027.
• The director was granted a stock option to purchase 6,209 shares at an exercise price of $8.22, vesting in monthly installments over 12 months starting June 11, 2026.
• Following these transactions, the director holds 165,390 shares directly and 329,675 shares indirectly through a family trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director equity compensation with no material impact on company operations or financial outlook.

Positives

• Continued alignment of director interests with shareholders through equity-based compensation.
• The director maintains a significant beneficial ownership position in the company.

Negatives

• None identified.

Risks

• Vesting of new equity awards is subject to the director's continued service to the company.

Future Outlook

The director's equity awards are subject to future vesting schedules, contingent upon continued service to the company.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance and director compensation practices within the life sciences and instrumentation sector, where equity-based incentives are common for board members.

Comparison to Industry Standards

• The use of RSU and stock option grants for board compensation is consistent with standard practices for publicly traded technology and life sciences companies.
• The vesting schedule of 12 months for options is standard for director retention.

Related Party Transactions

• The director maintains beneficial ownership of 329,675 shares held by the E. Kevin Hrusovsky 2012 Irrevocable Trust.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors.

Next Steps

• Vesting of 13,656 RSUs on June 11, 2027.
• Monthly vesting of 6,209 stock options over the next 12 months.

Key Dates

Keywords

908 Devices, MASS, Form 4, Insider Trading, Equity Compensation, Director Ownership